LVOne is a rapid diagnostic test for detecting Large Vessel Occlusion (LVO) stroke using a novel combination of D-dimer and GFAP biomarkers. Portable and stable at room temperature, it delivers results in minutes without additional equipment, enabling faster clinical decision-making in ambulances an...
Manufactured by
Pockit Diagnostics Ltd - Upfront diagnostics
Cambridge, United Kingdom
UpFront Diagnostics is a MedTech company pioneering point-of-care diagnostics for critical, time-sensitive conditions. The company s lead product, LVOne, is designed to revolutionise emergency stroke care by providing immediate, actionable diagnostic information. UpFront Diagnostics is committed to transforming patient outcomes by solving the current triage gap in stroke pathways.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ABCDx
Spain · 3 relevant products
Quidel China Ltd.
China · 2 relevant products
Cardiex Limited
China · 2 relevant products
14 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 25 closest product alternatives
ABCDx · Spain
A point-of-care diagnostic solution powered by advanced blood-based biomarkers for brain injuries. LVOCheck is designed for the selection and triage of large vessel occlusion (LVO) stroke patients to identify those requiring rapid treatment. The platform utilizes proprietary Software as a Medical Device technology to differentiate between ischemic and haemorrhagic stroke and detect mild traumatic brain injury.
Quidel China Ltd. · China
Point-of-care rapid diagnostic tests delivering accurate results within minutes. Enables faster diagnoses and better-informed clinical treatment decisions across multiple disease areas.
ABCDx · Spain
A rapid biochemical test that differentiates between ischemic stroke and intracranial hemorrhage within the first 4 hours from symptom onset. The test uses a combination of biomarkers to provide accurate diagnosis for stroke subtype determination, enabling rapid decision-making at point-of-care settings including ambulances and primary hospitals. This allows for timely initiation of specific treatment protocols such as reperfusion therapies.
22 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products